Skip to main content
. 2020 Sep 11;8:69. doi: 10.1186/s40560-020-00489-6

Table 1.

Patient characteristics

Total (N = 844) D5W (n = 365) Saline (n = 479) p value
Age, years 69 (55–77) 68 (56–75) 69 (55–78) 0.313
Male sex 584 (69.2) 244 (66.8) 340 (71.0) 0.202
Height, cm 164 (157–170) 164 (158–170) 164 (157–170) 0.593
Weight, kg 60 (50–70) 61 (51–70) 60 (50–70) 0.62
Body mass index 22 (20–25) 23 (20–25) 22 (20–25) 0.295
Comorbidity
 Heart failure 8 (0.9) 2 (0.5) 6 (1.3) 0.477
 Respiratory failure 17 (2.0) 5 (1.4) 12 (2.5) 0.325
 Liver cirrhosis 30 (3.6) 16 (4.4) 14 (2.9) 0.266
 Hematologic malignancy 45 (5.3) 20 (5.5) 25 (5.2) 0.878
 Metastatic malignancy 34 (4.0) 12 (3.3) 22 (4.6) 0.381
 Immunosuppression 95 (11.3) 39 (10.7) 56 (11.7) 0.662
Time from hospitalization to ICU, days 2 (0–7) 3 (0–8) 1 (0–6) 0.005
Patient category 0.005
 Planned surgical 291 (34.5) 150 (41.1) 141 (29.4)
 Nonplanned surgical 212 (25.1) 83 (22.7) 129 (26.9)
 Medical from ward 185 (21.9) 75 (20.5) 110 (23.0)
 Medical from ED 156 (18.5) 57 (15.6) 99 (20.7)
Main damaged organ 0.745
 Cardiovascular 342 (40.5) 156 (42.7) 186 (38.8)
 Neurologic 153 (18.1) 65 (17.8) 88 (18.4)
 Respiratory 127 (15.0) 49 (13.4) 78 (16.3)
 Digestive 120 (14.2) 51 (14.0) 69 (14.4)
 Other 102 (12.1) 44 (12.1) 58 (12.1)
APACHE III score 71 (56–88) 71 (57–86) 72 (54–88) 0.916
Data at ICU admission
 Sodium, mmol/L 140 (137–142) 140 (137–142) 140 (137–143) 0.274
 Chloride, mmol/L 107 (103–111) 108 (104–111) 107 (103–111) 0.105
 Blood glucose, mg/dL 137 (115–169) 136 (113–169) 138 (115–169) 0.525
 Baseline creatinine, mg/dL 0.85 (0.74–0.99) 0.84 (0.72–0.98) 0.85 (0.75–1.00) 0.448

Data are presented as median (interquartile range) or number (%)

APACHE III Acute Physiology and Chronic Health Evaluation III, D5W dextrose 5% in water, ED emergency department, ICU intensive care unit